ischemic metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism. Modified release (MR) Trimetazidine was developed to maintain effective plasma concentrations. The…
this study, the use of two modified chitosan derivatives (CS-ODEX and CS-OCNC) for the fabrication of mucoadhesive tablets for the oral delivery of Omeprazole (OME), is described. These ... vitro drug release…
test product and a reference product in healthy subjects. Significance: Trimetazidine, available as a modified-release dosage form, is approved as an add-on therapy for the treatment of stable ... these results, it can…
science of controlled release developed in the late 1940s and early 1950s by prolonged release products. The first drug associated to this mechanisms are associated with a patent ... this poster in assess the…
Hence in this current study, an effort has been made to develop a modified drug release by using tablet in tablet technique encompassing novel polymeric coating by using natural
disease and a plethora of other gastrointestinal disorders. Aiming at exploring the in vitro modified release profile of Mesalazine from solid hydrophilic matrices, we employed experimental design for the optimization…
objective behind this study was to formulate and evaluate Modified release tablet of Trazodone hydrochloride by using different hydrophilic and hydrophobic polymers by Wet granulation technology and to study
temperature, speed of pan rotation, air pressure, etc.) were investigated for the production of modified release pellets and dissolution kinetic curves were discussed. The optimized conditions confirm previous work…
present study is to evaluate the pharmaceutical quality of three generic products with modified-release containing the anti-diabetic active substance gliclazide and compare them with the original drug product…
Establishing a correlation between the in vitro dissolution profile of a Modified Release (MR) formulations and in the in vivo plasma concentration profiles have been great interest for a number ... years. Modified…
hours and an oral bioavailability 20-30%. Aiming at exploring the in vitro modified release profile of Mesalazine from solid hydrophilic matrices using Design of Experiments (DoE), we report herein ... results on its…
disease and a plethora of other gastrointestinal disorders. Aiming at exploring the in vitro modified release profile of Mesalazine from solid hydrophilic matrices, we employed experimental design for the optimization…
Based on these claims it was decided to extend our previous research on the modified release of this drug, by employing various compression coated systems. Compression coated tablets were comprised ... that the…
coated tablets composition used in this work constitute promising drug delivery systems for the modified release of per os administered Diclofenac Sodium
high amount of melatonin released immediately after administration, while the benefit of the modified release systems comes from the release of melatonin in small dosages during the entire night
drug delivery system becomes challenging when the drug product needs to be delivered in modified release pattern in elderly patients, especially since it is difficult to swallow for them. Multiparticulates ... mentioned…
adrenergic receptor antagonist. For many years, it has been available in a modified-release (MR) capsule formulation only, but recently, an oral-controlled absorption system (OCAS) tablet formulation has been
chronic disease with conventional formulation are very difficult. To rectify this problem, modified release system had come into picture which will prolong the release of drug from the formulation